News and reflections from the world of AI

    Aiforia announces CE-IVD mark for AI-supported breast cancer diagnostics

    First-of-its kind diagnostic tool Aiforia today announced the CE-IVD Mark for the Aiforia™ Clinical AI Model for Breast Cancer: Ki67, a widely used ...
    Written by Aiforia

    Aiforia Raises €12.6M in Series B Funding to Enhance Precision Diagnostics and Preclinical Analysis in Pathology

    Helsinki – June 3, 2021 - Aiforia, a software company providing AI-based solutions for clinical and preclinical image analysis in pathology, ...
    Written by Aiforia

    New Finnish consortium aims to enhance diagnostics and combat pandemics

    The COVID-19 pandemic has highlighted the importance of efficient diagnostic methods. Beyond battling pandemics, there are also significant ...
    Written by Aiforia
    March 15, 2021

    Aiforia appoints Swedbank as lead advisor to explore financing options

    Aiforia Technologies Oy ("Aiforia" or "the Company") has appointed Swedbank AB (publ) as their lead financial advisor to explore different financing options, including possibilities for an Initial Public Offering (IPO) by listing the Company's shares on Nasdaq Helsinki First North.
    Written by Aiforia
    February 4, 2021

    DECIDER project launches to improve diagnostics and treatment of ovarian cancer

    The European Union has funded a project to improve personalized treatments for ovarian cancer with nearly 15 million euros for five years. The international DECIDER project has partners from 14 organizations in seven EU countries.
    Written by Aiforia
    January 19, 2021

    Aiforia feature: Multi-channel Images and Analysis

    Unlimited channels, limitless data  Aiforia’s multi-channel viewing and analysis capabilities can be applied to any image allowing for hundreds of channels to be imported and processed.
    Written by Aiforia
    1 2 3 4